Navigation Links
Coalition for 21st Century Medicine Endorses 'Patient Access to Critical Lab Tests Act'
Date:3/30/2009

- Legislation Seeks to Ensure Medicare Beneficiaries Have Access to Life-Saving Diagnostic Tests, Encourage Continued Innovation of Personalized Medicine -

WASHINGTON, March 30 /PRNewswire-USNewswire/ -- The Coalition for 21st Century Medicine today announced its full endorsement for the Patient Access to Critical Lab Tests Act, legislation introduced in the U.S. House of Representatives on March 25th by Representatives Jason Altmire (D-PA), Anna Eshoo (D-CA) and Tim Murphy (R-PA). The legislation will provide Medicare beneficiaries enhanced access to advanced diagnostic laboratory tests that can help improve the lives of millions of patients suffering from debilitating diseases. Additionally, the bill will encourage continued innovation in the burgeoning and promising field of personalized medicine.

Mapping the human genome has enabled revolutionary advances in understanding a wide variety of diseases and ushered in an era where treatments can be tailored to individual patients based on their DNA and the specific molecular character of their disease. Complex diagnostic laboratory tests make such "personalized medicine" possible. By understanding the molecular nature of disease, these new technologies increasingly allow clinicians and patients to pick individualized treatment options, rather than basing treatment choices on broad assessments of what works best for a population.

Current Medicare regulations thwart access to these important tests and discourage innovation by requiring hospitals to act as middlemen in the billing process. Laboratories are required to bill hospitals, and hospitals are required to bill Medicare. An access problem arises because hospitals are reluctant to assume the financial risk that the laboratory service will be covered and reimbursed by Medicare. The Patient Access to Critical Lab Tests Act would permit independent laboratories that develop and perform certain qualifying genetic, genomic or proteomic tests and cancer chemosensitivity assays to bill Medicare directly.

The Coalition for 21st Century Medicine applauds these Representatives for pursuing solutions to break down the barriers that block patients from receiving timely access to these important diagnostic tests.

About the Coalition for 21st Century Medicine

The Coalition for 21st Century Medicine represents some of the world's most innovative diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists and patient advocacy groups - all linked by a common mission to develop advanced diagnostics that improve the quality of healthcare for patients. For more information about the Coalition for 21st Century Medicine please visit http://www.twentyfirstcenturymedicine.org.


'/>"/>
SOURCE The Coalition for 21st Century Medicine
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Business, Labor, Academia and Bioscience Groups to Launch New Coalition to Promote Medical Innovation and Spark Economic Growth
2. Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes
3. Coalition to Protect Senior Care Applauds Senate Finance Health Subcommittee Hearing on Long Term Care Improvement as Part of Broad Health Care Reform
4. MARC Coalition Welcomes CMS Extension of MSP Reporting Requirements and Clarification of Reporting Thresholds
5. Broad Coalition Offers Plan to Improve Health Care Quality and Affordability
6. Young Survival Coalition and Living Beyond Breast Cancer Announce Support for Rep. Wasserman Schultzs The Early Act
7. Coalition to Protect Senior Care Urges House Ways and Means Panel to Reject MedPAC Recommendations on SNF Medicare Funding
8. MMR Information Systems Offers First Bilingual Personal Health Record Through The Latino Coalition
9. Tony Coelho is Named New Chair of Coalition for Comparative Effectiveness Research
10. The Coalition for Ethical Imaging Announces Support for Diagnostic Imaging Bills Introduced in Texas Legislature
11. Food & Water Watch and International Coalition Members to Protest World Water Forum in Istanbul
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... As part of its ongoing ... February 2016. Each webinar features a dynamic expert and thoughtful presentation to give ... patients and facilities. Both events are free to attend, but registration is ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... (VRI) within Healthcare, recently partnered with Heart City Health Center to ... nearly 23 years, Heart City Health Center has provided the Elkhart community with ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intermedix announced on Wednesday that ... an emergency medicine professional association, to support the organization's newly established physician group ... of Emergency Medicine, or AAEM, seeks to empower emergency physicians to control their ...
(Date:2/10/2016)... ... 10, 2016 , ... Compliancy Group LLC is pleased to ... throughout the country. The Guard was specifically designed to handle each element required ... regulatory updates, and compliance coaching. , In addition to meeting the compliance needs ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... charity program created to assist the local community. Pledging to select a new ... nonprofit organizations in the area. Their goal is to bring community awareness to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , Feb. 10, 2016 Immune Pharmaceuticals ... company, announced today that it has filed a patent ... and other cancers. --> ... cancer by administration of Ceplene (histamine dihydrochloride) in combination ... methods of predicting the efficacy of Ceplene and IL-2 ...
(Date:2/10/2016)... BEVERLY HILLS, Calif. , Feb. 10, 2016 /PRNewswire/ ... the "Company") today announced a 1-for-100 reverse split of ... at the opening of trading on Thursday, February 11, ... split-adjusted basis under new CUSIP number 76303T308 and temporary ... stock will commence trading under the ticker symbol (RCHA).  ...
(Date:2/10/2016)... -- Astellas Pharma Inc. (TSE: 4503, President and CEO: ... successfully completed, through its indirect wholly-owned subsidiary Laurel Acquisition ... and outstanding shares of common stock of Ocata Therapeutics, ... , "Ocata") for a price of US$8.50 per share ... commenced the Tender Offer on November 19, 2015, U.S. ...
Breaking Medicine Technology: